1. Merck leaps into COVID vaccine race — Evofem Biosciences gets FDA approval for new non-hormonal contraceptive — Sanofi sells $13 billion stake in Regeneron — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Removing kyphoplasty distributors?

Discussion in 'CareFusion' started by Anonymous, Apr 28, 2015 at 4:24 PM.

  1. Anonymous

    Anonymous Guest

    Any truth to this rumor? I hear they only want to keep highest volume distributors and try to steal the rest of our business back using direct reps. They barely survived a couple of years ago because we saved their a$$. We sold where they couldn't. Had the same joker for years in Florida with no business, bring in a distributor and their sales skyrocket. Now they want to try and screw us. Wtf?
    Do they really think an underpaid rep will be able to double the business? Maybe the new company will just sell off this loser division.
  2. Anonymous

    Anonymous Guest

    Bone cement is a dead tech. BD will extingquish the product line, liken it to Witch craft.
  3. anonymous

    anonymous Guest